High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 1, 2006, Pages 262-269

  Sarquis, Marta S ^c,e,f   Weber, Frank ^a,c,g   Shen, Lei ^c   Broelsch, Christoph E ^g   Jhiang, Sissy M ^c   Zedenius, Jan ^h   Frilling, Andrea ^g   Eng, Charis ^a,b,c,d,i  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f Bolsista do CNPq   (Brazil)

^g UNIVERSITY OF DUISBURG ESSEN   (Germany)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CANCER PATIENT; CARCINOGENESIS; CONTROLLED STUDY; DNA DETERMINATION; GENE FREQUENCY; GENE MAPPING; GENOME IMPRINTING; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THYROID ADENOMA; THYROID CARCINOMA; THYROID GLAND; TUMOR SUPPRESSOR GENE;

ADENOMA; CARCINOMA, PAPILLARY, FOLLICULAR; CHROMOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; GENOMIC IMPRINTING; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; THYROID NEOPLASMS;

MAMMALIA;

EID: 30344441509     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1880     Document Type: Article

References (30)

1. DeLellis RA, Williams ED 2004 Thyroid and parathyroid tumors: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization Classification of Tumors. Pathology, Genetics Tumors of Endocrine Organs. 1st ed. Lyon, France: IARC Press; 51-56
2. Tallini G 2002 Molecular pathobiology of thyroid neoplasms. Endocr Pathol 13:271-288
3. Xing M, Cohen Y, Mambo E, Tallini G, Udelsman R, Ladenson PW, Sidransky D 2004 Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis. Cancer Res 64:1664-1668
4. Tzen CY, Huang YW, Fu YS 2003 Is atypical follicular adenoma of the thyroid a preinvasive malignancy? Hum Pathol 34:666-669
5. Weber F, Aldred MA, Morrison CD, Plass C, Frilling A, Broelsch CE, Waite KA, Eng C 2005 Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis. J Clin Endocrinol Metab 90:1149-1155
6. Jirtle RL 1999 Genomic imprinting and cancer. Exp Cell Res 248:18-24
7. Momparler RL 2003 Cancer epigenetics. Oncogene 22:6479-6483
8. Tycko B 2000 Genomic imprinting and human neoplasia. In: Ehrlich M, ed. DNA Alterations in cancer: genetic and epigenetic changes. 1st ed. Natick, MA: Eaton Publishing; 333-349
9. Makos M, Nelkin BD, Reiter RE, Gnarra JR, Brooks J, Isaacs W, Linehan M, Baylin SB 1993 Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res 15:2719-2722
10. Morison IM, Reeve AE 1998 A catalogue of imprinted genes and parent-of origin effects in humans and animal. Hum Mol Genet 7:1599-1609
11. Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD, Eng C 2005 Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 90:2512-2521
12. Li C, Wong WH 2001 Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98:31-36
13. Ward LS, Brenta G, Medvedovic M, Fagin JA 1998 Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J Clin Endocrinol Metab 83:525-530
14. Paulsen M, Ferguson-Smith AC 2001 DNA methylation in genomic imprinting, development, and disease. J Pathol 195:97-110
15. Tilghman SM 1999 The sins of the fathers and mothers: genomic imprinting in mammalian development. Cell 96:185-193
16. Yeh JJ, Marsh DJ, Zedenius J, Dwight T, Delbridge L, Robinson BG, Eng C 1999 Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways. Genes Chromosomes Cancer 26:322-328
17. Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, Klibanski A 2003 A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 88:5119-5126
18. Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, Catchpoole D, Grundy R, Ferguson-Smith AC, Maher ER 2005 Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer 92:1574-1580
19. Kim DJ, Park JY, Lee MH, Sohn YK 2004 The role of microsatellite instability at chromosome 11p15.5 in the progression of breast ductal carcinoma. J Korean Med Sci 19:698-703
20. Fukuzawa R, Hata J, Hayashi Y, Ikeda H, Reeve AE 2003. Beckwith-Wiedemann syndrome-associated hepatoblastoma: wnt signal activation occurs later in tumorigenesis in patients with 11p15.5 uniparental disomy. Pediatr Dev Pathol 6:299-306
21. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B 1993 Tumor suppressor activity of H19 RNA. Nature 351:665-667
22. Kaur R, Nagpal JK, Das BR 2005 Polymorphism in IGF-2 as a surrogate marker for predisposition towards tobacco chewing-mediated oral cancer. Tumour Biol 26:147-152
23. Buiting K, Dittrich B, Gross S, Greger V, Lalande M, Robinson W, Mutirangura A, Ledbetter D, Horsthemke B 1993 Molecular definition of the Prader-Willi syndrome chromosome region and orientation of the SNRPN gene. Hum Mol Genet 2:1991-1994
24. Gray TA, Saitoh S, Nicholls RD 1999 An imprinted, mammalian bicistronic transcript encodes two independent proteins. Proc Natl Acad Sci USA 96:5616-5621
25. Davies HD, Leusink GL, McConnell A, Deyell M, Cassidy SB, Fick GH, Coppes MJ 2003 Myeloid leukemia in Prader-Willi syndrome. J Pediatr 142:174-178
26. Cooper B, Schneider S, Bohl J, Jiang Y, Beaudet A, Vande Pol S 2003 Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology 306:87-99
27. Lau JC, Hanel ML, Wevrick R 2004 Tissue-specific and imprinted epigenetic modifications of the human NDN gene. Nucleic Acids Res 32:3376-3382
28. Roque L, Rodrigues R, Pinto A, Moura-Nunes V, Soares J 2003 Chromosome imbalances in thyroid follicular neoplasm: a comparison between follicular adenomas and carcinomas. Genes Chromosomes Cancer 36:292-302
29. Vasko VV, Ferrand M, DI Cristofaro J, Carayon P, Henry J. F., De Micco C 2003 Specific pattern of. RAS oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab 88:2745-2752
30. Vasko VV, Gaudart J, Allasia Claude, Savchenko V, Cristofaro JD, Saji M, Ringel MD, De Micco C 2004 Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma. Eur J Endocrinol 151:779-786